Randomized, Open-Label, Phase 3 Trial of
Nivolumab and Ipilimumab versus Platinum-Doublet Chemotherapy in Early Stage NSCLC (CA209-816), NCT02998528
PURPOSE OF THIS CLINICAL RESEARCH TRIAL
The purpose of this study is to determine the safety and effectiveness of nivolumab and ipilimumab compared to chemotherapy in the treatment of Early Stage Non-Small Cell Lung Cancer.
MORE DETAILS ON THIS TRIAL:
16161 / NCT02998528 / Open 3-9-2017 / Call PM 9-6-2019